secwatch / observer
8-K filed March 27, 2025, 7:59 PM ET ticker BCYC CIK 0001761612
leadership confidence high sentiment positive materiality 0.70

Bicycle Therapeutics appoints Alessandro Riva to board, names Felix Baker chairman, promotes Eric Westin to CMO

BICYCLE THERAPEUTICS PLC

item 5.02item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Pierre Legault

Director
BCYC · BICYCLE THERAPEUTICS PLC
Effective
2025-06-17
Filed
March 27, 2025, 7:59 PM ET
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
Departed

Santiago Arroyo

Chief Development Officer
BCYC · BICYCLE THERAPEUTICS PLC
Effective
2025-03-24
Filed
March 27, 2025, 7:59 PM ET
Santiago Arroyo, M.D., Ph.D., notified the Board of his resignation as the Company's Chief Development Officer, effective March 24, 2025.
Departed

Richard Kender

Director
BCYC · BICYCLE THERAPEUTICS PLC
Effective
2025-06-17
Filed
March 27, 2025, 7:59 PM ET
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
Appointed

Alessandro Riva

Director
BCYC · BICYCLE THERAPEUTICS PLC
Effective
2025-03-25
Filed
March 27, 2025, 7:59 PM ET
appointed Alessandro Riva, M.D., to the Board and the Scientific Committee of the Board, effective as of the close of business on March 25, 2025, New York City time.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Pierre Legault resigned as Director at BICYCLE THERAPEUTICS PLC.

Action
resigned
Role
Director
Exact text from the filing
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Santiago Arroyo resigned as Chief Development Officer at BICYCLE THERAPEUTICS PLC.

Action
resigned
Role
Chief Development Officer
Exact text from the filing
Santiago Arroyo, M.D., Ph.D., notified the Board of his resignation as the Company's Chief Development Officer, effective March 24, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Kender resigned as Director at BICYCLE THERAPEUTICS PLC.

Action
resigned
Role
Director
Exact text from the filing
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Alessandro Riva was appointed as Director at BICYCLE THERAPEUTICS PLC.

Action
appointed
Role
Director
Exact text from the filing
appointed Alessandro Riva, M.D., to the Board and the Scientific Committee of the Board, effective as of the close of business on March 25, 2025, New York City time.
View on SEC.gov

BICYCLE THERAPEUTICS PLC filing history →

Source: SEC EDGAR
accession 0001104659-25-028531
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.